Retinoic acid receptor expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2642-2650

  Fitzgerald, Patrick ^a   Teng, Min ^b   Chandraratna, Roshantha A S ^b   Heyman, Richard A ^a   Allegretto, Elizabeth A ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

^b ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ALITRETINOIN; BEXAROTENE; ESTROGEN RECEPTOR; RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

AMINOBENZOIC ACIDS; ANTINEOPLASTIC AGENTS; BENZOATES; BREAST NEOPLASMS; CELL DIVISION; CHROMANS; FEMALE; HUMANS; NICOTINIC ACIDS; NUCLEAR PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; TETRAHYDRONAPHTHALENES; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0030787752     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thaller, C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68: 397-406, 1992.
2. Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., Kratzeisen, C. I., Rosenberger, M., Lovey, A., and Grippo, J. F. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature (Lond.), 355: 359-361, 1992.
3. Allenby, G., Bocquel, M. T., Saunders, M., Kazmer, S., Speck, T., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J. F., Chambon, P., and Levin, A. A. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA, 90: 30-34, 1993.
4. Allegretto, E. A., McClurg, M. R., Lazarchik, S. B., Clemm, D. L., Kerner, S. A., Elgort, M. G., Boehm, M. F., White, S. K., Pike, J. W., and Heyman, R. A. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast: correlation with hormone binding and effects of metabolism. J. Biol. Chem., 268: 26625-26633, 1993.
5. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. Retinoid receptors. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine. New York: Raven Press Ltd., pp. 319-349, 1994.
6. Hoffmann, C., and Eichele, G. Retinoids in development. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman, (eds.), The Retinoids: Biology, Chemistry and Medicine. New York: Raven Press, pp. 387-442, 1994.
7. Lohnes, D., Kastner, P., Dierich, A., Mark, M., LeMeur, M., and Chambon, P. Function of retinoic acid receptor-γ in the mouse. Cell, 73: 643-658, 1993.
8. Lufkin, T., Lohnes, D., Mark, M., Dierich, A., Gorry, P., Gaub, M. P., LeMeur, M., and Chambon, P. High postnatal lethality and testis degeneration in retinoic acid receptor a mutant mice. Proc. Natl. Acad. Sci. USA. 90: 7225-7229, 1993.
9. Lohnes, D., Mark, M., Mendelsohn, C., Dolle, P., Dierich, A., Gorry, P., Gansmuller, , A., and Chambon, P. Function of the retinoic acid receptors during development: craniofacial and skeletal abnormalities in RAR double mutants. Development (Camb.), 120: 2723-2748, 1994.
10. Mendelsohn, C., Lohnes, D., Decimo, D., Lufkin, T., LeMeur, M., Chambon, P., and Mark, M. Function of retinoic acid receptors during development: multiple abnormalities at various stages of organogenesis in RAR double mutants. Development (Camb.), 120: 2749-2771, 1994.
11. Moon, R. C., Mehta, R. G., and Detrisac, C. J. Retinoids as chemopreventative agents for breast cancer. Cancer Detect. Prev., 16: 73-79, 1992.
12. Anzano, M. A., Byers, S. W., Smith, J. M., Peer, C. W., Mullen, L. T., Brown, C. C., Roberts, A. B., and Sporn, M. B. Prevention of breast cancer in the rat with 9-cis retinoic acid as a single agent and in combination with tamoxifen. Cancer Res., 54: 4614-4617, 1994.
13. Albini, A., Graf, J., Kitten, G. T., Kleinman, H. K., Martin, G. R., Veilette, A., and Lippman, M. E. 17 β-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane. Proc. Natl. Acad. Sci. USA, 83: 8182-8186, 1986.
14. McGuire, W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol., 5: 428-433, 1978.
15. Jordan, V. C. The strategic use of antiestrogens to control the development and growth of breast cancer. Cancer (Phila.), 70: 977-982, 1992.
16. Roman, S. D., Clarke, C. L., Hall, R. E., Alexander, I. E., and Sutherland, R. L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res., 52: 2236-2242, 1992.
17. van der Burg, B., van der Leede, B., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol., 91: 149-157, 1993.
18. Shao, Z., Shen, Z., and Fontana, J. A. Expression of the retinoic acid nuclear receptors and retinoid X receptor gene in human breast cancer. Chung-Hua Chung Liu Tsa Chih, 17: 425-428, 1995.
19. Han, Q. X., Allegretto, E. A., Shao, Z. M., Kute, T. E., Ordonez, J., Aisner, S. C., and Fontana, J. A. Elevated expression of retinoic acid receptor-α in estrogen receptor-positive breast carcinomas as detected by immunohistochemistry. Diagn. Mol. Pathol., 6: 42-48, 1997.
20. Sheikh, M. S., Shao, Z., Chen, J., Hussain, A., Jenen, A. M., and Fontana, J. A. Estrogen receptor-negative breast carcinoma cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell. Biochem., 53: 394-404, 1993.
21. Sheikh, M. S., Shao, Z., Li, X., Dawson, M., Jetten, A. M., Wu, S., Conley, B. A., Garcia, M., Rochefort, H., and Fontana, J. A. Retinoid resistant estrogen receptor negative human breast carcinoma cells transfected with retinoic acid receptor α acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem., 269: 21440-21447, 1994.
22. Titcomb, M. W., Gottardis, M. M., Pike, J. W., and Allegretto, E. A. Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extracts. Mol. Endocrinol., 8: 870-877, 1994.
23. Boehm, M. F., Zhang, L., Zhi, L., McClurg, M. R., Berger, E., Wagoner, M., Mais, D. E., Suto, C. M., Davies, P. J. A., Heyman, R. A., and Nadzan, A. M. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem., 38: 3146-3155, 1995.
24. Boehm, M. F., Zhang, L., Badea, B., White, S. K., Mais, D. E., Berger, E., Suto, C. M., Goldman, M. E., and Heyman, R. A. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem., 37: 2930-2941, 1994.
25. Zhang, L., Nadzan, A. M., Heyman, R. A., Love, D. L., Mais, D. E., Croston, G., Lamph, W. W., and Boehm, M. F. Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells. J. Med. Chem., 39: 2659-2663, 1996.
26. Loeliger, P., Bollag, W., and Mayer, H. Arotinoids, a new class of highly active retinoids, Eur. J. Med. Chem., 15: 9-15, 1980.
27. Apfel, C., Bauer, F., Crettaz, M., Forni, L., Kamber, M., Kaufmann, F., LeMotte, P., Pirson, W., and Klaus, M. A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc. Natl. Acad. Sci. USA, 89: 7129-7133, 1992.
28. Bernard, B. A., Bernardon, J., Delescluse, C., Martin, B., Lenoir, M. C., Maignan, J., Charpentier, B., Pilgrim, W. R., Reichert, U., and Shroot, B. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun., 186: 977-983, 1992.
29. Johnson, A. T., Klein, E. S., Gillet, S. J., Wang, L., Song, T. K., Pino, M. E., and Chandraratna, R. A. S. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem., 38: 4764-4767, 1995.
30. Teng, M., Duong, T. T., Klein, E. S., Pino, M. E., and Chandraratna, R. A. S. Identification of a retinoic acid receptor α subtype specific agonist. J. Med. Chem., 39: 3035-3038, 1996.
31. Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., and Brenner, H. J. Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer, 15: 659-670, 1979.
32. Roy, B., Taneja, R., and Chambon, P. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ-, or RARγ-selectivc ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol., 15: 6481-6487, 1995.
33. 3. J. Biol. Chem., 270: 23906-23909, 1995.
34. Fontana, J. A. Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp. Cell. Biol., 55: 136-144, 1987.
35. Rizvi, N. A., Marshall, J. L., Loewen, G. R., Ulm, E. H., Gill, G. M., Truglia, J. A., Ness, E., Clarke, R., and Hawkins, M. J. A phase I study of Targretin™, an RXR-selective retinoid agonist. Proc. Am. Assoc. Cancer Res., 37: 165, 1996.
36. Lacroix, A., L'Heureux, N., and Bhat, P. V. Cytoplasmic retinoic acid-binding protein in retinoic acid-resistant human breast cancer sublines. J. Natl. Cancer Inst., 73: 793-800, 1984.
37. Roman, S. D., Ormandy, C. J., Manning, D. L., Blamey, R. W., Nicholson, R. I., Sutherland, R. L., and Clarke, C. L. Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res., 53: 5940-5945, 1993.
38. Rishi, A. K., Gerald, T. M., Shao, Z-M., Li, X-S., Baumann, R. G., Dawson, M. I., and Fontana, J. A. Regulation of the human retinoic acid receptor α gene in the estrogen receptor negative breast carcinoma cell lines SKBR-3 and MDA-MB-435. Cancer Res., 56: 5246-5252, 1996.
39. van der Leede, B. M., Geertzema, J., Vroom, T. M., Decimo, D., Lutz, Y., van der Saag, P. T., and van der Burg, B. Immunohistochemical analysis of retinoic acid receptor-α in human breast tumors. Am. J. Pathol., 148: 1905-1914, 1996.
40. Look, J., Landwehr, J., Bauer, F., Hoffmann, A. S., Bluethmann, H., and Lemotte, P. Marked resistance of RARγ-deficient mice to the toxic effects of retinoic acid. Am. J. Physiol., 269: E91-E98, 1995.
41. Chen, S., Ostrowski, J., Whiting, G., Roalsvig, T., Hammer, L., Currier. S. J., Honeyman, J., Kwasniewski, B., Yu, K. L., Sterzycki, R., Kim, C. U., Starrett, J., Mansuri, M., and Reczek, P. R. Retinoic acid receptor γ mediates topical retinoid efficacy and irritation in animal models. J. Invest. Dermatol., 104: 779-783, 1995.
42. Lotan, R., Dawson, M. I., Zou, C-C., Jong, L., Lotan, D., and Zou, C-P. Enhanced efficacy of combinations of retinoic acid-and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.
43. Apfel, C. M., Kamber, M., Klaus, M., Mohr, P., Keidel, S., and LeMotte, P. K. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor. J. Biol. Chem., 51: 30765-30772, 1995.
44. Kizaki, M., Dawson, M. I., Heyman, R., Elstner, E., Morosetti, R., Pakkala, S., Chen, D. L., Ueno, H., Chao, W., Morikawa, M., Ikeda, Y., Heber, D., Pfahl, M., and Koeffler, H. P. Effects of novel retinoid X receptor-selective ligands on myeloid leukemic differentiation and proliferation in vitro. Blood, 87: 1977-1984, 1996.